Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis
Anna Malczewska, Kjell Öberg, Beata Kos‐Kudła
Endocrine Connections (2020) Vol. 10, Iss. 1, pp. 110-123
Open Access | Times Cited: 24

Showing 24 citing articles:

Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms
Daisuke Takayanagi, Hourin Cho, Erika Machida, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1119-1119
Open Access | Times Cited: 41
Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives
Xianbin Zhang, Yibao Fan, Rui Jing, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) [Aktualizacja zaleceń ogólnych dotyczących postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
Beata Kos‐Kudła, Wanda Fołtyn, Anna Malczewska, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 387-454
Open Access | Times Cited: 35
Management recommendations for pancreatic manifestations of von Hippel–Lindau disease
Shachar Laks, Rachel van Leeuwaarde, Dhaval Patel, et al.
Cancer (2021) Vol. 128, Iss. 3, pp. 435-446
Open Access | Times Cited: 34
Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy
Irvin M. Modlin, Mark Kidd, Andrea Frilling, et al.
Annals of Surgery (2021) Vol. 274, Iss. 3, pp. 481-490
Open Access | Times Cited: 31
An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
Michele Bevere, Αναστάσιος Γκουντάκος, Filippo Maria Martelli, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 303-303
Open Access | Times Cited: 9
New Developments in Gastric Neuroendocrine Neoplasms
Klaire Exarchou, Nathan Stephens, Andrew R. Moore, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 1, pp. 77-88
Open Access | Times Cited: 14
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective
Laura Mariën, Odeta Islam, Siddharth Chhajlani, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 12, pp. 1833-1851
Closed Access | Times Cited: 7
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms
Anna Battistella, Matteo Tacelli, Paola Mapelli, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 4-5, pp. 155-169
Closed Access | Times Cited: 2
Neuroendocrine neoplasms of the small intestine and the appendix — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita cienkiego i wyrostka robaczkowego — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
Tomasz Bednarczuk, Anna Zemczak, Marek Bolanowski, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 549-583
Open Access | Times Cited: 11
Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
Violetta Rosiek, Angelika Kogut, Beata Kos‐Kudła
Cancers (2023) Vol. 15, Iss. 13, pp. 3282-3282
Open Access | Times Cited: 5
Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
Wei-Xuan Pan, Xin-Mu Zhang, Shaolong Hao, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4174-4185
Open Access | Times Cited: 5
A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy
Karel Pacák, Mark Kidd, Leah Meuter, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 11, pp. 731-744
Open Access | Times Cited: 11
A Neuroendocrine Biomarker Revolution From Monoanalyte to Multianalyte Biomarkers in Non-Functioning Gastro-entero-pancreatic Neuroendocrine Neoplasms
Camilla O. Hoff, João Manzi, Raphaella Ferreira, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104460-104460
Closed Access | Times Cited: 1
Genomic Landscape of Pancreatic Neuroendocrine Tumors and Implications for Clinical Practice
Ana De Jesus‐Acosta, Chirayu Mohindroo
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Circulating biomarkers of gastroenteropancreatic and lung neuroendocrine neoplasms: “The times they are a changin”
Irvin M. Modlin, Mark Kidd, Lisa Bodei, et al.
Current Opinion in Endocrine and Metabolic Research (2021) Vol. 18, pp. 243-253
Closed Access | Times Cited: 6
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms
Isa Jacoba, H. Christian Weber
Current Opinion in Endocrinology Diabetes and Obesity (2023) Vol. 30, Iss. 3, pp. 175-180
Closed Access | Times Cited: 2
Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms
Tadashi Toyohara, Michihiro Yoshida, Katsuyuki Miyabe, et al.
Cancer Science (2023) Vol. 114, Iss. 12, pp. 4571-4582
Open Access | Times Cited: 2
Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms”
Violetta Rosiek, Monika Wójcik-Giertuga, Beata Kos‐Kudła
Cancer Treatment and Research Communications (2022) Vol. 31, pp. 100533-100533
Open Access | Times Cited: 3
The Clinicopathological Characteristics and Surgical Treatment of Gastrointestinal Neuroendocrine Neoplasm—A 10-Year Single-Center Experience
Michał Serafin, Beata Jabłońska, Emila Senderek, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4892-4892
Open Access
Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms
Florian Bösch, A. Altendorf-Hofmann, Vanessa Koliogiannis, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 1895-1903
Open Access | Times Cited: 2
Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives
Elettra Merola, Andrea Michielan, Umberto Rozzanigo, et al.
World Journal of Gastrointestinal Surgery (2022) Vol. 14, Iss. 2, pp. 78-106
Open Access | Times Cited: 1
Moderne molekulare und bildgebende Diagnostik bei neuroendokrinen Neoplasien des Pankreas
Costanza Chiapponi, Christiane J. Bruns
Deleted Journal (2022) Vol. 93, Iss. 8, pp. 731-738
Closed Access
Moderne molekulare und bildgebende Diagnostik bei neuroendokrinen Neoplasien des Pankreas
Costanza Chiapponi, Christiane J. Bruns
best practice onkologie (2022) Vol. 17, Iss. 12, pp. 598-605
Closed Access
Page 1

Scroll to top